Skip to main content
Premium Trial:

Request an Annual Quote

On the Verge

Two CRISPR-based biotech companies, one in Europe and one in the US, aim to start clinical trials this year, the Financial Times reports.

The Switzerland-based CRISPR Therapeutics has applied to regulators in Europe to seek approval to test its treatment for beta thalassemia, while the US-based Editas Medicine plans to soon ask the US Food and Drug Administration for the go-ahead to test its treatment for a type of congenital blindness, FT says. It adds that CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics hope to apply their approaches to a suite of diseases, including cancer, cystic fibrosis, hemophilia and Duchenne muscular dystrophy.

Diseases for which there are few available treatments will be the first to be tackled by gene-editing approaches, Katrine Bosley, chief executive of Editas, tells FT, as questions of safety and risk are still being addressed.

Clinicians in China have also been moving ahead with human studies of CRISPR-based treatments. For instance, Hangzhou Cancer Hospital researchers are using CRISPR to knock out the PD-1 gene within cancer patients' T cells to ramp up their immune response to tumor cells. Meanwhile, University of Pennsylvania researchers are about to begin their own trial editing the PD-1 and TCR genes within the T cells of patients with myeloma, melanoma, or sarcoma.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.